'Game-changing' Alzheimer's drug Lecanemab gets the green light - but it won't be available on the NHS

22 August 2024, 08:22 | Updated: 22 August 2024, 10:07

A woman receives Lecanemab, sold under the brand name Leqembi, at a hospital in Tokyo
A woman receives Lecanemab, sold under the brand name Leqembi, at a hospital in Tokyo. Picture: Alamy

By Asher McShane

The first drug that has been shown to slow the progression of Alzheimer's disease is set to be approved by the UK’s medicines regulator.

Listen to this article

Loading audio...

Lecanemab, developed by pharmaceutical company Eisai, is an antibody treatment that binds to amyloid, a protein which builds up in the brains of people living with Alzheimer's disease.

It is designed to help clear the build-up and slow down cognitive decline in people with the condition and is given to patients via an intravenous drip fortnightly.

The decision from the Medicines and Healthcare products Regulatory Agency (MHRA) is set to be announced shortly, but it is understood to have approved the treatment.

Read more: Search resumes in Sicily for last missing Bayesian superyacht passenger after five bodies found in wreck

Read more: Pictured: mum and 3 children aged 1, 5 and 9 who died in 'deliberate' Bradford house fire as man arrested for murder

It will also need the green light from health service spending watchdog the National Institute for Health and Care Excellence (Nice) before it is rolled out on the NHS in England.

Lecanemab is already licensed in the US, where it costs about £20,000 per patient per year, although it was rejected by the European Medicines Agency (EMA) in late July.

The EMA said the benefits of lecanemab did not counterbalance the risk of people suffering serious side-effects such as bleeding and swelling in the brain.

It also said the effects of the drug on delaying cognitive decline were small.

A similar drug called donanemab, which is developed by Eli Lilly, is also being assessed for approval in the UK by medicine regulators.

NHS England estimates between 50,000 and 280,000 patients might be eligible for the new treatments.

Prior to being given the drugs, they will need to have a baseline MRI scan and then either a Pet-CT scan or lumbar puncture to confirm Alzheimer's.

The ruling by the safety watchdog will mean it can be prescribed privately in Britain for the first time.

The National Institute of Health and Care Excellence will then advise on whether it should be rolled out by the NHS.

An MHRA spokesperson said: “We are currently completing a rigorous assessment of the evidence supporting lecanemab in the treatment of Alzheimer’s disease. Further information will be communicated in due course.”

Prof John Hardy, one of the world’s leading researchers in the field, said the drug was “game-changing”, describing it as “the biggest breakthrough in Alzheimer’s for decades”.

More Latest News

See more More Latest News

Comp image for LBC of various tennis players ahead of Wimbledon 2025

When is Wimbledon 2025?

Couple forced to steal back their own car after police 'too stretched' to investigate - despite Airtag showing exact location

Couple forced to steal back their own car after police 'too stretched' to investigate - despite Airtag showing location

Breaking News

Father and nine-year-old daughter die in house fire - as girl, 11, remains in critical condition in hospital

Exclusive
Fresh Warnings Over ‘Doomsday Ship’ Off Kent Coast – A National Security Threat Hiding in Plain Sight

Britain’s doomsday ship is a sitting duck – 1,400 tonnes of explosives just off Kent coast as fresh warnings emerge

Exclusive
Occupational therapy

'Sector in crisis': Anger at underfunding after mum claims boy ‘turned away by NHS as he's a private school pupil’

The NHS needs one million regular blood donors to maintain its blood supply, officials have said. NHS Blood and Transplant (NHSBT) said more must be done to avoid a "red alert", which means that blood supply is so low there is a threat to public safety

One million blood donors needed as stocks run dangerously low in the wake of NHS cyber attack

.

All the Tony Award 2025 winners as Sarah Snook triumphs

Cadbury factory building in Bournville Birmingham

Cadbury discontinues popular chocolate biscuit treat after just five years

Emma Raducanu (pictured preparing for the  inaugural women’s Queen’s Club Championships this week),has discussed her stalking ordeal

Emma Raducanu says she is 'wary' when going out after stalker ordeal in Dubai

Murder inquiry after boy, 14, stabbed in Manchester

Boy, 14, stabbed to death in 'horrific incident' as two teenagers arrested on suspicion of murder

A photo posted on Telegram purportedly showing activists with their hands up on board the Madleen

Greta Thunberg’s ‘Freedom Flotilla’ boarded and seized by Israeli forces as she says she’s been ‘kidnapped’

Protesters help a journalist after an injury during a protest in Compton after federal immigration authorities conducted operations.

British photographer undergoes surgery after being shot with 'sponge' bullets during LA protests

Exclusive
Wes Streeting has told junior doctors threatening to strike it's the "last thing the NHS needs" and they need to "change their tactics" and call off their threats.

More doctors strikes 'last thing the NHS needs' and BMA must call off threats, says Health Secretary

The Israel Foreign Ministry said "Greta Thunberg is currently on her way to Israel".

Israel says it will ‘show Greta Thunberg October 7 attacks footage’ after Gaza-bound aid boat diverted

Greta Thunberg is attempting to open up a humanitarian corridor to Gaza.

Israel 'circling aid flotilla' as Israel vows to use 'any measures necessary' to stop Greta Thunberg's ship reaching Gaza

Boys playing beach cricket

Finance experts suggest ways to teach children good money habits over the summer